1. Home
  2. MRVI vs GCBC Comparison

MRVI vs GCBC Comparison

Compare MRVI & GCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • GCBC
  • Stock Information
  • Founded
  • MRVI 2014
  • GCBC 1889
  • Country
  • MRVI United States
  • GCBC United States
  • Employees
  • MRVI N/A
  • GCBC N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • GCBC Banks
  • Sector
  • MRVI Health Care
  • GCBC Finance
  • Exchange
  • MRVI Nasdaq
  • GCBC Nasdaq
  • Market Cap
  • MRVI 262.9M
  • GCBC 364.4M
  • IPO Year
  • MRVI 2020
  • GCBC 1998
  • Fundamental
  • Price
  • MRVI $1.77
  • GCBC $21.41
  • Analyst Decision
  • MRVI Hold
  • GCBC
  • Analyst Count
  • MRVI 10
  • GCBC 0
  • Target Price
  • MRVI $7.59
  • GCBC N/A
  • AVG Volume (30 Days)
  • MRVI 3.3M
  • GCBC 79.4K
  • Earning Date
  • MRVI 05-07-2025
  • GCBC 04-29-2025
  • Dividend Yield
  • MRVI N/A
  • GCBC 1.69%
  • EPS Growth
  • MRVI N/A
  • GCBC N/A
  • EPS
  • MRVI N/A
  • GCBC 1.54
  • Revenue
  • MRVI $259,185,000.00
  • GCBC $65,848,000.00
  • Revenue This Year
  • MRVI N/A
  • GCBC N/A
  • Revenue Next Year
  • MRVI $14.23
  • GCBC N/A
  • P/E Ratio
  • MRVI N/A
  • GCBC $13.90
  • Revenue Growth
  • MRVI N/A
  • GCBC N/A
  • 52 Week Low
  • MRVI $1.68
  • GCBC $20.00
  • 52 Week High
  • MRVI $11.56
  • GCBC $37.25
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 29.16
  • GCBC 34.56
  • Support Level
  • MRVI $1.68
  • GCBC $21.12
  • Resistance Level
  • MRVI $1.89
  • GCBC $23.13
  • Average True Range (ATR)
  • MRVI 0.17
  • GCBC 1.20
  • MACD
  • MRVI 0.03
  • GCBC 0.02
  • Stochastic Oscillator
  • MRVI 15.56
  • GCBC 33.25

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About GCBC Greene County Bancorp Inc.

Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.

Share on Social Networks: